A study of STX-478 alone and in combination with other anticancer drugs in participants with advanced solid tumors.

Status

Recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-504807-94-00

Acronym

STX-478-101

Enrollment

201

Registered

2023-11-20

Start date

2023-12-26

Completion date

Unknown

Last updated

2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer; Advanced solid tumors including but not limited to gynecologic Cancer; Head and Neck Squamous Cell Carcinoma

None listed

Sex/Gender

All

Age

18 Years to No maximum

Belgium, France, Ireland, Italy, Netherlands, Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026